Gossamer Total Assets from 2010 to 2025

GOSS Stock

USD 0.93 0.03 3.67%

Gossamer Bio Total Assets yearly trend continues to be comparatively stable with very little volatility. Total Assets will likely drop to about 293.4 M in 2025. Total Assets is the total value of all owned resources that are expected to provide future economic benefits to the business, including cash, investments, accounts receivable, inventory, property, plant, equipment, and intangible assets. View All Fundamentals

Total Assets

First Reported

2016-12-31

Previous Quarter

373.4 M

Current Value

350.9 M

Quarterly Volatility

165.2 M

Covid

Check Gossamer Bio financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Gossamer Bio's main balance sheet or income statement drivers, such as Interest Income of 1.5 M, Interest Expense of 8.2 M or Selling General Administrative of 36.5 M, as well as many indicators such as Price To Sales Ratio of 0.0, Dividend Yield of 0.0 or PTB Ratio of 2.1. Gossamer financial statements analysis is a perfect complement when working with Gossamer Bio Valuation or Volatility modules.

Check out the analysis of Gossamer Bio Correlation against competitors.

For more information on how to buy Gossamer Stock please use our How to Invest in Gossamer Bio guide.

Latest Gossamer Bio's Total Assets Growth Pattern

Below is the plot of the Total Assets of Gossamer Bio over the last few years. Total assets refers to the total amount of Gossamer Bio assets owned. Assets are items that have some economic value and are expended over time to create a benefit for the owner. These assets are usually recorded in Gossamer Bio books under different categories such as cash, marketable securities, accounts receivable,prepaid expenses, inventory, fixed assets, intangible assets, other assets, marketable securities, accounts receivable, prepaid expenses and others. It is the total value of all owned resources that are expected to provide future economic benefits to the business, including cash, investments, accounts receivable, inventory, property, plant, equipment, and intangible assets. Gossamer Bio's Total Assets historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Gossamer Bio's overall financial position and show how it may be relating to other accounts over time.

View

Last Reported 311.92 M

10 Years Trend

Slightly volatile

Compare to Others All Fundamentals

Total Assets

Timeline

Gossamer Total Assets Regression Statistics

	Arithmetic Mean	174,154,388
	Geometric Mean	5,102,273
	Coefficient Of Variation	109.89
	Mean Deviation	174,046,262
	Median	239,419,000
	Standard Deviation	191,382,758
	Sample Variance	36627.4T
	Range	539.4M
	R-Value	0.79
	Mean Square Error	14817.9T
	R-Squared	0.62
	Significance	0.0003
	Slope	31,713,797
	Total Sum of Squares	549410.4T

Gossamer Total Assets History

	2025	293.4 M
	2024	358.7 M
	2023	311.9 M
	2022	272.4 M
	2021	343.7 M
	2020	539.4 M
	2019	426.6 M

Other Fundumenentals of Gossamer Bio

Intangibles To Total Assets

Gossamer Bio Total Assets component correlations

	Total Assets	Total Stockholder Equity	Net Tangible Assets	Net Debt	Retained Earnings	Accounts Payable	Long Term Debt	Long Term Debt Total	Total Liab	Total Current Assets	Capital Surpluse	Net Invested Capital	Net Working Capital	Net Receivables	Deferred Long Term Liab	Capital Stock	Common Stock	Property Plant Equipment	Short Term Debt	Short Long Term Debt
Total Assets		-0.53	0.65	-0.11	-0.75	0.81	0.78	0.92	0.77	1.0	0.86	0.89	1.0	-0.08	-0.27	0.59	0.59	0.55	0.46	-0.27
Total Stockholder Equity	-0.53		-0.44	0.27	0.38	-0.15	-0.51	-0.45	-0.42	-0.52	-0.53	-0.51	-0.5	0.12	-0.25	0.05	0.05	-0.27	-0.05	-0.25
Net Tangible Assets	0.65	-0.44		-0.51	-0.18	0.31	0.24	0.35	0.04	0.64	0.44	0.78	0.66	0.41	0.09	0.07	0.07	0.79	-0.12	0.09
Net Debt	-0.11	0.27	-0.51		-0.52	0.16	0.34	0.17	0.15	-0.11	0.29	-0.02	-0.14	-0.36	-0.58	0.66	0.66	-0.24	0.76	-0.58
Retained Earnings	-0.75	0.38	-0.18	-0.52		-0.81	-0.95	-0.85	-0.77	-0.75	-0.94	-0.74	-0.73	0.48	0.51	-0.89	-0.89	-0.15	-0.88	0.51
Accounts Payable	0.81	-0.15	0.31	0.16	-0.81		0.81	0.81	0.74	0.81	0.78	0.75	0.82	-0.51	-0.58	0.82	0.82	0.11	0.68	-0.58
Long Term Debt	0.78	-0.51	0.24	0.34	-0.95	0.81		0.82	0.8	0.78	0.96	0.77	0.75	-0.57	-0.34	0.77	0.77	0.06	0.76	-0.34
Long Term Debt Total	0.92	-0.45	0.35	0.17	-0.85	0.81	0.82		0.9	0.92	0.86	0.74	0.92	-0.2	-0.45	0.73	0.73	0.42	0.65	-0.45
Total Liab	0.77	-0.42	0.04	0.15	-0.77	0.74	0.8	0.9		0.78	0.73	0.49	0.76	-0.42	-0.3	0.6	0.6	0.06	0.6	-0.3
Total Current Assets	1.0	-0.52	0.64	-0.11	-0.75	0.81	0.78	0.92	0.78		0.87	0.89	1.0	-0.09	-0.27	0.6	0.6	0.54	0.46	-0.27
Capital Surpluse	0.86	-0.53	0.44	0.29	-0.94	0.78	0.96	0.86	0.73	0.87		0.89	0.84	-0.32	-0.33	0.77	0.77	0.34	0.72	-0.33
Net Invested Capital	0.89	-0.51	0.78	-0.02	-0.74	0.75	0.77	0.74	0.49	0.89	0.89		0.89	-0.09	-0.27	0.61	0.61	0.57	0.47	-0.27
Net Working Capital	1.0	-0.5	0.66	-0.14	-0.73	0.82	0.75	0.92	0.76	1.0	0.84	0.89		-0.08	-0.31	0.59	0.59	0.56	0.44	-0.31
Net Receivables	-0.08	0.12	0.41	-0.36	0.48	-0.51	-0.57	-0.2	-0.42	-0.09	-0.32	-0.09	-0.08		0.31	-0.42	-0.42	0.74	-0.5	0.31
Deferred Long Term Liab	-0.27	-0.25	0.09	-0.58	0.51	-0.58	-0.34	-0.45	-0.3	-0.27	-0.33	-0.27	-0.31	0.31		-0.77	-0.77	-0.03	-0.7	1.0
Capital Stock	0.59	0.05	0.07	0.66	-0.89	0.82	0.77	0.73	0.6	0.6	0.77	0.61	0.59	-0.42	-0.77		1.0	0.12	0.93	-0.77
Common Stock	0.59	0.05	0.07	0.66	-0.89	0.82	0.77	0.73	0.6	0.6	0.77	0.61	0.59	-0.42	-0.77	1.0		0.12	0.93	-0.77
Property Plant Equipment	0.55	-0.27	0.79	-0.24	-0.15	0.11	0.06	0.42	0.06	0.54	0.34	0.57	0.56	0.74	-0.03	0.12	0.12		-0.04	-0.03
Short Term Debt	0.46	-0.05	-0.12	0.76	-0.88	0.68	0.76	0.65	0.6	0.46	0.72	0.47	0.44	-0.5	-0.7	0.93	0.93	-0.04		-0.7
Short Long Term Debt	-0.27	-0.25	0.09	-0.58	0.51	-0.58	-0.34	-0.45	-0.3	-0.27	-0.33	-0.27	-0.31	0.31	1.0	-0.77	-0.77	-0.03	-0.7

Click cells to compare fundamentals

About Gossamer Bio Financial Statements

Gossamer Bio shareholders use historical fundamental indicators, such as Total Assets, to determine how well the company is positioned to perform in the future. Although Gossamer Bio investors may analyze each financial statement separately, they are all interrelated. The changes in Gossamer Bio's assets and liabilities, for example, are also reflected in the revenues and expenses on on Gossamer Bio's income statement. Understanding these patterns can help investors time the market effectively. Please read more on our fundamental analysis page.

		Last Reported	Projected for Next Year
	Total Assets	358.7 M	293.4 M

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.

Explore Investing Ideas

Additional Tools for Gossamer Stock Analysis

When running Gossamer Bio's price analysis, check to measure Gossamer Bio's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Gossamer Bio is operating at the current time. Most of Gossamer Bio's value examination focuses on studying past and present price action to predict the probability of Gossamer Bio's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Gossamer Bio's price. Additionally, you may evaluate how the addition of Gossamer Bio to your portfolios can decrease your overall portfolio volatility.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC